DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click
HERE to register or log in.
Accession Number:
ADA455577
Title:
Targeting Stat3 With G-Quartet Oligonucleotides in Metastic Prostate Cancer
Descriptive Note:
Final rept. 1 Apr 2003-31 Mar 2006
Corporate Author:
BAYLOR COLL OF MEDICINE HOUSTON TX
Report Date:
2006-04-01
Pagination or Media Count:
46.0
Abstract:
During the three year funding period, we have well developed a novel and potent Stat3 inhibitor, which represents a promising class of anti-cancer drug in treatment of human cancers, including prostate, breast, head and neck, and long cancers. We appreciate to get a DOD funding for supporting this project. However, the funding period is too short to fulfill the preclinical drug development.
Distribution Statement:
APPROVED FOR PUBLIC RELEASE